Hamlin Capital Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Hamlin Capital Management's PFE Position: Q2 2020 in Review
Hamlin Capital Management sold out of Pfizer (PFE) in Q2 2020, closing a stake of 2,314,277 shares — an estimated $71.7M sold.
Hamlin Capital Management first reported a position in PFE in Q1 2016 and held it in 17 quarters. The position peaked at $117M in Q3 2018. 2,441 funds tracked by Wall St. Rank hold PFE as of Q2 2020.
- Hamlin Capital Management reported no remaining Pfizer position as of Q2 2020 after selling out during the quarter.
- Hamlin Capital Management sold 2,314,277 Pfizer shares in Q2 2020, an estimated $71.7M.
- Hamlin Capital Management first reported a position in Pfizer in Q1 2016 and held it in 17 quarters.
- Hamlin Capital Management's Pfizer position peaked at $117M in Q3 2018.
- 2,441 funds tracked by Wall St. Rank held Pfizer as of Q2 2020.
Based on Hamlin Capital Management's 13F filing for Q2 2020, filed 15 Jul 2020.